BACKGROUND AND PURPOSE: rtPA is an effective treatment for AIS, yet it is substantially underused due to the increased risk of HT. Recent work suggests that permeability-related information can be extracted from routine T2*-based perfusion images by measuring the rR of the contrast agent. Given that other T2*-based measures have recently been proposed, the purpose of this study was to evaluate 4 such permeability measures in identifying patients with AIS who will proceed to HT. MATERIALS AND METHODS: Eighteen patients with AIS were examined within a mean of 3.3 +/- 1.4 hours postonset. Dynamic T2*-weighted imaging consisted of a single-shot EPI following a bolus of gadodiamide. HT was determined on follow-up CT or MR imaging at 24-72 hours. Mean values of rR, Peak Height, Recovery, as well as Slope were calculated and analyzed on the basis of follow-up HT status. RESULTS: Eight patients proceeded to HT. The mean rR for patients with HT was significantly greater than that for patients without HT (0.22 +/- 0.06 versus 0.14 +/- 0.06, P = .006), while there was a trend toward decreased %Recovery in patients with HT (76 +/- 6 versus 82 +/- 11%, P = .092). There was a significant negative correlation between %Recovery and rR (r = -0.88, P < .001). No significant differences or trends were detected with respect to Peak Height or Slope. CONCLUSIONS: Both rR and %Recovery can be readily extracted from a routine perfusion MR imaging dataset and show potential for identifying HT during the acute phase poststroke.
BACKGROUND AND PURPOSE: rtPA is an effective treatment for AIS, yet it is substantially underused due to the increased risk of HT. Recent work suggests that permeability-related information can be extracted from routine T2*-based perfusion images by measuring the rR of the contrast agent. Given that other T2*-based measures have recently been proposed, the purpose of this study was to evaluate 4 such permeability measures in identifying patients with AIS who will proceed to HT. MATERIALS AND METHODS: Eighteen patients with AIS were examined within a mean of 3.3 +/- 1.4 hours postonset. Dynamic T2*-weighted imaging consisted of a single-shot EPI following a bolus of gadodiamide. HT was determined on follow-up CT or MR imaging at 24-72 hours. Mean values of rR, Peak Height, Recovery, as well as Slope were calculated and analyzed on the basis of follow-up HT status. RESULTS: Eight patients proceeded to HT. The mean rR for patients with HT was significantly greater than that for patients without HT (0.22 +/- 0.06 versus 0.14 +/- 0.06, P = .006), while there was a trend toward decreased %Recovery in patients with HT (76 +/- 6 versus 82 +/- 11%, P = .092). There was a significant negative correlation between %Recovery and rR (r = -0.88, P < .001). No significant differences or trends were detected with respect to Peak Height or Slope. CONCLUSIONS: Both rR and %Recovery can be readily extracted from a routine perfusion MR imaging dataset and show potential for identifying HT during the acute phase poststroke.
Authors: A Kassner; D J Annesley; X P Zhu; K L Li; I D Kamaly-Asl; Y Watson; A Jackson Journal: J Magn Reson Imaging Date: 2000-02 Impact factor: 4.813
Authors: James R Ewing; Robert A Knight; Tavarekere N Nagaraja; John S Yee; Vijaya Nagesh; Polly A Whitton; Lian Li; Joseph D Fenstermacher Journal: Magn Reson Med Date: 2003-08 Impact factor: 4.668
Authors: Robert A Knight; Kishor Karki; James R Ewing; George W Divine; Joseph D Fenstermacher; Clifford S Patlak; Tavarekere N Nagaraja Journal: J Cereb Blood Flow Metab Date: 2009-03-25 Impact factor: 6.200
Authors: Oh Young Bang; Jeffrey L Saver; Jeffry R Alger; Samir H Shah; Brian H Buck; Sidney Starkman; Bruce Ovbiagele; David S Liebeskind Journal: Stroke Date: 2008-11-26 Impact factor: 7.914
Authors: Oh Young Bang; Brian H Buck; Jeffrey L Saver; Jeffry R Alger; Sa Rah Yoon; Sidney Starkman; Bruce Ovbiagele; Doojin Kim; Latisha K Ali; Nerses Sanossian; Reza Jahan; Gary R Duckwiler; Fernando Viñuela; Noriko Salamon; J Pablo Villablanca; David S Liebeskind Journal: Ann Neurol Date: 2007-08 Impact factor: 10.422
Authors: Piotr Walczak; Joanna Wojtkiewicz; Adam Nowakowski; Aleksandra Habich; Piotr Holak; Jiadi Xu; Zbigniew Adamiak; Moussa Chehade; Monica S Pearl; Philippe Gailloud; Barbara Lukomska; Wojciech Maksymowicz; Jeff Wm Bulte; Miroslaw Janowski Journal: J Cereb Blood Flow Metab Date: 2016-01-01 Impact factor: 6.200
Authors: Nicholas Vincent; Noah Stier; Songlin Yu; David S Liebeskind; Danny Jj Wang; Fabien Scalzo Journal: Proceedings (IEEE Int Conf Bioinformatics Biomed) Date: 2015-12-17
Authors: Fabien Scalzo; Jeffry R Alger; Xiao Hu; Jeffrey L Saver; Krishna A Dani; Keith W Muir; Andrew M Demchuk; Shelagh B Coutts; Marie Luby; Steven Warach; David S Liebeskind Journal: Magn Reson Imaging Date: 2013-04-13 Impact factor: 2.546
Authors: A R Jain; M Jain; A R Kanthala; D Damania; L G Stead; H Z Wang; B S Jahromi Journal: AJNR Am J Neuroradiol Date: 2013-04-18 Impact factor: 3.825
Authors: Anna K Heye; Michael J Thrippleton; Paul A Armitage; Maria Del C Valdés Hernández; Stephen D Makin; Andreas Glatz; Eleni Sakka; Joanna M Wardlaw Journal: Neuroimage Date: 2015-10-20 Impact factor: 6.556
Authors: Anna K Heye; Ross D Culling; Maria Del C Valdés Hernández; Michael J Thrippleton; Joanna M Wardlaw Journal: Neuroimage Clin Date: 2014-09-10 Impact factor: 4.881
Authors: Alexander D Horsch; Jan Willem Dankbaar; Tom van Seeters; Joris M Niesten; Merel J A Luitse; Pieter C Vos; Irene C van der Schaaf; Geert-Jan Biessels; Yolanda van der Graaf; L Jaap Kappelle; Willem P Th M Mali; Birgitta K Velthuis Journal: Clin Neuroradiol Date: 2015-02-27 Impact factor: 3.649